Patents by Inventor Ejvind Jensen

Ejvind Jensen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
    Patent number: 8158583
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Grant
    Filed: May 12, 2009
    Date of Patent: April 17, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Kristian Tage Hansen, Dorthe Kot Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Gottschalk Bøving, Morten Schlein
  • Protracted GLP-1 Compositions
    Publication number: 20100099620
    Abstract: Thixotropic compositions containing GLP-1 compounds have protracted action.
    Type: Application
    Filed: December 18, 2009
    Publication date: April 22, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Ejvind Jensen, Klavs Holger Jørgensen
  • Soluble Pharmaceutical Compositions for Parenteral Administration Comprising a GLP-1 Peptide and an Insulin Peptide of Short Time Action for Treatment of Diabetes and Bulimia
    Publication number: 20090286716
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Application
    Filed: May 12, 2009
    Publication date: November 19, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Kristian Tage Hansen, Dorthe Kot Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Gottschalk Boving, Morten Schlein
  • Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
    Publication number: 20060287221
    Abstract: Pharmaceutical composition for parenteral administration comprising a meal related insulin peptide and an insulinotropic peptide.
    Type: Application
    Filed: May 3, 2006
    Publication date: December 21, 2006
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Knudsen, Kristian Hansen, Dorthe Engelund, Svend Ludvigsen, Lars Hansen, Claude Bonde, Ejvind Jensen, Tine Elisabeth Boving, Morten Schlein
  • Washable floor mat
    Publication number: 20050031827
    Abstract: A washable floor mat has a tufted pile textile surface (1) and an elastomer backing layer (2). The textile surface (1) includes tufts of a blended yarn that includes at least 40% cotton fibers and at least 25% polyester fibres. The cotton and polyester fibres together comprise at least 90% of the total fibre content of the blended yarn.
    Type: Application
    Filed: January 23, 2003
    Publication date: February 10, 2005
    Inventors: Aage Lang, Albert Poelmans, Ejvind Jensen
  • Protracted GLP-1 compositions
    Publication number: 20040220105
    Abstract: Thixotropic compositions containing GLP-1 compounds have protracted action.
    Type: Application
    Filed: May 26, 2004
    Publication date: November 4, 2004
    Inventors: Ejvind Jensen, Klavs Jorgensen
  • Protracted GLP-1 compositions
    Publication number: 20010006943
    Abstract: Glucagon-like peptide-1 (GLP-1) compositions having protracted action and methods for treating diabetes mellitus with same. Thixotropic GLP-1 compositions may further contain a phenolic or alcoholic aromatic compound, a preservative, and or divalent metal compounds.
    Type: Application
    Filed: January 23, 2001
    Publication date: July 5, 2001
    Inventors: Ejvind Jensen, Klavs Holger Jorgensen